You have 8 free searches left this month | for more free features.

BRCA2 mutation carrier

Showing 1 - 25 of 3,274

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

Active, not recruiting
  • BRCA1 Mutation Carrier
  • +8 more
  • soy isoflavones
  • +7 more
  • Los Angeles, California
    University of Southern California
Nov 11, 2021

Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • blood sample for BRCA2 mutation detection
  • (no location specified)
Jun 1, 2023

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

BRCA1/2 Flu Vaccine

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 16, 2022

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

Identification of a Genetic Predisposition to ProstAte Cancer

Active, not recruiting
  • Prostate Cancer in BRCA1 and BRCA2 Carriers
  • PSA test
  • Prostate Biopsy
  • Sutton, Surrey, United Kingdom
    Cancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Mar 28, 2023

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • +7 more
      • (no location specified)
      Aug 1, 2022

      Searching for Novel Germline Mutations in Lobular Breast Cancer

      Recruiting
      • Lobular Breast Carcinoma
      • +3 more
      • Illumina panel
      • Milan, Italy
        European Institute of Oncology
      Sep 12, 2022

      BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)

      Recruiting
      • BRCA1/2 Mutation
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 7, 2021

      Digital Genetic Counselor for BRCA1/2 Mutation Carrier Testing

      Unknown status
      • BRCA Mutations
        • (no location specified)
        Jan 29, 2020

        ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

        Recruiting
        • ATM Gene Mutation
        • +16 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 27, 2022

        InheriteD brEast caNcer iTalian regIsTrY A

        Recruiting
        • Breast Cancer
          • Aviano, Pordenone, Italy
          • +11 more
          Apr 26, 2023

          An Intervention to Increase Genetic Testing in Families Who May

          Recruiting
          • BRCA1 Mutation
          • +21 more
          • Intervention Arm At-risk Relative/ARR Contacts
          • +5 more
          • Basking Ridge, New Jersey
          • +7 more
          Nov 22, 2022